Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics

Wang, Xuanting; Sacramento, Carolina Q.; Jockusch, Steffen; Chaves, Otávio Augusto; Tao, Chuanjuan; Rodrigues, Natalia Fintelman; Chien, Minchen; Temerozo, Jairo Ramos; Xaioxu, Li; Kumar, Shiv; Xie, Wei; Patel, Dinshaw J.; Meyer, Cindy; Garzia, Aitor; Tuschi, Thomas; Bozza, Patrícia Torres; Russo, James J.; Souza, Thiago Moreno L.; Ju, Jingyue

This article is a Preprint

Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.

Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics

Wang, Xuanting; Sacramento, Carolina Q.; Jockusch, Steffen; Chaves, Otávio Augusto; Tao, Chuanjuan; Rodrigues, Natalia Fintelman; Chien, Minchen; Temerozo, Jairo Ramos; Xaioxu, Li; Kumar, Shiv; Xie, Wei; Patel, Dinshaw J.; Meyer, Cindy; Garzia, Aitor; Tuschi, Thomas; Bozza, Patrícia Torres; Russo, James J.; Souza, Thiago Moreno L.; Ju, Jingyue.

Affiliation

Wang, Xuanting; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, USA / Department of Chemical Engineering, Columbia University, New York, NY, USA..

bioRxiv preprint; .

Preprint in En | PREPRINT-FIOCRUZ | ID: ppf-48718

Key words

SARS-CoV-2; Combinação de drogas antivirais; Inibição; Polimerase e a exonuclease; Terapia potencial; COVID-19; Antiviral Drugs; Inhibit; SARS-CoV-2; Polymerase and Exonuclease; Potential COVID-19 Therapeutics

Fulltext

Add to My VHL

XML

Search on Google